The Company reported third-quarter 2025 net loss of $9.99 per share and adjusted net earnings per diluted share of$0.75. "We delivered solid results in the third quarter, reflecting continued progress by our teams around the world," said Damien McDonald, Chief Executive Officer of Enovis. "Execution was driven by double- digit growth in extremities and consistent performance across Prevention & Recovery. Enovis Announces Third Quarter 2025 Results Dallas, TX, November 6, 2025 (GLOBE NEWSWIRE)—Enovis™ Corpo ...